BDBM50557485 Prn-1008::Prn1008::Rilzabrutinib

SMILES CC(C)(\C=C(/C#N)C(=O)N1CCC[C@H](C1)n1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc12)N1CCN(CC1)C1COC1

InChI Key InChIKey=LCFFREMLXLZNHE-UHFFFAOYSA-N

Data  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 50557485   

TargetTyrosine-protein kinase BTK(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM50557485(Rilzabrutinib | Prn-1008 | Prn1008)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of BTK (unknown origin) One-hour enzymatic assay without pre-incubationMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM50557485(Rilzabrutinib | Prn-1008 | Prn1008)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of BTK (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis methodMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetTyrosine-protein kinase BTK(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM50557485(Rilzabrutinib | Prn-1008 | Prn1008)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of BTK (unknown origin) using peptide substrate in presence of ATPMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetTyrosine-protein kinase TXK(Human)
Principia Biopharma, A Sanofi

Curated by ChEMBL
LigandPNGBDBM50557485(Rilzabrutinib | Prn-1008 | Prn1008)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of RLK (unknown origin) using peptide substrate in presence of ATPMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetTyrosine-protein kinase Tec(Human)
Principia Biopharma, A Sanofi

Curated by ChEMBL
LigandPNGBDBM50557485(Rilzabrutinib | Prn-1008 | Prn1008)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of TEC (unknown origin) using peptide substrate in presence of ATPMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Principia Biopharma, A Sanofi

Curated by ChEMBL
LigandPNGBDBM50557485(Rilzabrutinib | Prn-1008 | Prn1008)
Affinity DataIC50: 1nMAssay Description:Inhibition of BMX (unknown origin) using peptide substrate in presence of ATPMore data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetTyrosine-protein kinase Blk(Human)
Principia Biopharma, A Sanofi

Curated by ChEMBL
LigandPNGBDBM50557485(Rilzabrutinib | Prn-1008 | Prn1008)
Affinity DataIC50: 6.30nMAssay Description:Inhibition of BLK (unknown origin) using peptide substrate in presence of ATPMore data for this Ligand-Target Pair
In DepthDetails
PubMed